Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management Read more
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers Read more
Sun Pharma’s phase 3 clinical studies evaluating ILUMYA in active psoriatic arthritis met their primary endpoint Read more